Page last updated: 2024-08-21

aminoacetonitrile and Brain Neoplasms

aminoacetonitrile has been researched along with Brain Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brandl, MB; Chang, J; Cui, K; Jin, G; Li, F; Mao, Y; Nie, F; Rodriguez, A; Wang, L; Wong, ST; Xue, Z; Zhao, H	1

Other Studies

1 other study(ies) available for aminoacetonitrile and Brain Neoplasms

Article	Year
The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models. Breast cancer research and treatment, 2012, Volume: 131, Issue:2 Topics: Aminoacetonitrile; Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Protein Kinase Inhibitors; Sirolimus; TOR Serine-Threonine Kinases	2012

Article

Year

The effect of mTOR inhibition alone or combined with MEK inhibitors on brain metastasis: an in vivo analysis in triple-negative breast cancer models.

Breast cancer research and treatment, 2012, Volume: 131, Issue:2

Topics: Aminoacetonitrile; Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Protein Kinase Inhibitors; Sirolimus; TOR Serine-Threonine Kinases

2012